Mustang Financial Statements From 2010 to 2026

MBIO Stock

USD 0.91 0.01 1.11%

Mustang Bio's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Mustang Bio's valuation are provided below:

Market Capitalization

6.6 M

Revenue

-50 K

Earnings Share

(6.71)

Revenue Per Share

(0)

We have found one hundred twenty available fundamental ratios for Mustang Bio, which can be analyzed and compared to other ratios and to its peers in the industry. Self-guided Investors are advised to check Mustang Bio's last-minute fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. As of the 13th of February 2026, Market Cap is likely to drop to about 59.3 M. In addition to that, Enterprise Value is likely to drop to about 52.7 M

Check Mustang Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mustang Bio's main balance sheet or income statement drivers, such as Interest Expense of 5.5 K, Selling General Administrative of 8.5 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.009 or Days Sales Outstanding of 0.0. Mustang financial statements analysis is a perfect complement when working with Mustang Bio Valuation or Volatility modules.

Build AI portfolio with Mustang Stock

Check out the analysis of Mustang Bio Correlation against competitors.

To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.

Mustang Bio Balance Sheet

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Short and Long Term Debt Total

959.2 K

1 M

6.4 M

Very volatile

Other Current Liabilities

5 M

5.4 M

3.4 M

Slightly volatile

Total Current Liabilities

9.7 M

14.5 M

7.8 M

Slightly volatile

Accounts Payable

9 M

8.6 M

3.1 M

Slightly volatile

Common Stock Total Equity

8.5 K

8.1 K

4.1 K

Slightly volatile

Common Stock Shares Outstanding

4.3 M

7 M

3.2 M

Slightly volatile

Non Current Liabilities Total

624.9 K

657.8 K

4.5 M

Very volatile

Capital Surpluse

333.2 M

317.4 M

144.3 M

Slightly volatile

Other Stockholder Equity

244.5 M

451.8 M

171.8 M

Slightly volatile

Total Liabilities

15.4 M

15.2 M

11.3 M

Slightly volatile

Short and Long Term Debt

1.4 M

1.1 M

2 M

Slightly volatile

Short Term Debt

761.2 K

410.4 K

1.7 M

Slightly volatile

Common Stock

5.1 K

5.8 K

3.6 K

Slightly volatile

Total Assets

8 M

8.4 M

43.7 M

Very volatile

Cash

5.8 M

6.2 M

36.1 M

Very volatile

Cash And Short Term Investments

5.8 M

6.2 M

38.7 M

Very volatile

Liabilities And Stockholders Equity

8 M

8.4 M

43.7 M

Very volatile

Total Current Assets

7.4 M

7.7 M

39.8 M

Very volatile

Accumulated Other Comprehensive Income

522.4 K

549.9 K

3.7 M

Slightly volatile

Other Liabilities

366 K

310.5 K

202.2 K

Slightly volatile

Property Plant And Equipment Net

386.5 K

406.8 K

3.9 M

Slightly volatile

Net Receivables

661 K

462.3 K

392.5 K

Slightly volatile

Other Current Assets

1.7 M

1.6 M

1 M

Slightly volatile

Property Plant And Equipment Gross

9.3 M

8.9 M

5.6 M

Slightly volatile

Capital Stock

6.3 K

5.8 K

4.5 K

Slightly volatile

Non Current Liabilities Other

1.7 M

2.2 M

1.3 M

Slightly volatile

Long Term Debt Total

9.7 M

11 M

12 M

Slightly volatile

Capital Lease Obligations

750.7 K

790.2 K

2 M

Slightly volatile

Mustang Bio Income Statement

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Interest Expense

5.5 K

5.8 K

738.8 K

Pretty Stable

Selling General Administrative

8.5 M

4.8 M

5.4 M

Slightly volatile

Other Operating Expenses

17.7 M

18.7 M

26.4 M

Slightly volatile

Research Development

9.2 M

9.7 M

20.2 M

Slightly volatile

Total Operating Expenses

17.7 M

18.7 M

25.9 M

Slightly volatile

Interest Income

201 K

211.6 K

344.7 K

Slightly volatile

Non Recurring

8.4 M

11.6 M

7.9 M

Slightly volatile

Reconciled Depreciation

1.7 M

946.5 K

902.3 K

Slightly volatile

Selling And Marketing Expenses

292 K

328.5 K

358.6 K

Slightly volatile

Mustang Bio Cash Flow Statement

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Sale Purchase Of Stock

789.2 K

830.7 K

20.1 M

Slightly volatile

Depreciation

1.3 M

946.5 K

851.2 K

Slightly volatile

Other Non Cash Items

5.6 M

4.1 M

5.4 M

Pretty Stable

Change To Netincome

9.7 M

12.7 M

7.7 M

Slightly volatile

Cash Flows Other Operating

10.4 M

18.2 M

10.6 M

Slightly volatile

End Period Cash Flow

5.8 M

6.2 M

36.4 M

Very volatile

Begin Period Cash Flow

7.6 M

8 M

37.9 M

Pretty Stable

Financial Ratios

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Dividend Yield

0.009

0.0101

0.0111

Slightly volatile

Capex To Depreciation

0.056

0.0589

660

Slightly volatile

Payables Turnover

0.36

0.32

0.2458

Slightly volatile

Cash Per Share

1.22

1.28

14.8658

Slightly volatile

Days Payables Outstanding

582

933

629

Slightly volatile

Income Quality

0.51

0.65

0.548

Slightly volatile

Current Ratio

0.75

0.78

7.0615

Slightly volatile

Capex Per Share

0.0145

0.0152

1.2904

Slightly volatile

Interest Debt Per Share

0.16

0.1425

2.9272

Slightly volatile

Debt To Assets

0.096

0.0849

0.0887

Slightly volatile

Days Of Payables Outstanding

582

933

629

Slightly volatile

Long Term Debt To Capitalization

0.22

0.33

0.2541

Slightly volatile

Quick Ratio

0.75

0.78

7.0615

Slightly volatile

Net Income Per E B T

0.83

0.93

1.0195

Slightly volatile

Cash Ratio

0.59

0.62

6.3427

Slightly volatile

Free Cash Flow Operating Cash Flow Ratio

1.25

1.15

1.1719

Slightly volatile

Debt Ratio

0.096

0.0849

0.0887

Slightly volatile

Mustang Bio Valuation Data

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Market Cap

59.3 M

62.4 M

6.7 B

Slightly volatile

Enterprise Value

52.7 M

55.5 M

6.6 B

Slightly volatile

Mustang Fundamental Market Drivers

Mustang Upcoming Events

	3rd of April 2024 Upcoming Quarterly Report	View
	10th of May 2024 Next Financial Report	View
	31st of December 2023 Next Fiscal Quarter End	View
	3rd of April 2024 Next Fiscal Year End	View
	30th of September 2023 Last Quarter Report	View
	31st of December 2022 Last Financial Announcement	View

About Mustang Bio Financial Statements

Mustang Bio investors utilize fundamental indicators, such as revenue or net income, to predict how Mustang Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

	Last Reported	Projected for Next Year
Current Deferred Revenue	172.5 K	181.1 K
Cost Of Revenue	946.5 K	1.3 M

Pair Trading with Mustang Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Mustang Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mustang Bio will appreciate offsetting losses from the drop in the long position's value.

Moving together with Mustang Stock

0.72	DWTX	Dogwood Therapeutics	Pair Corr
0.8	EDIT	Editas Medicine Earnings Call This Week	Pair Corr

Moving against Mustang Stock

0.6	IMMP	Immutep Ltd ADR	Pair Corr
0.58	ENGN	enGene Holdings Common	Pair Corr
0.57	DSGN	Design Therapeutics	Pair Corr
0.33	KYTX	Kyverna Therapeutics	Pair Corr

The ability to find closely correlated positions to Mustang Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Mustang Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Mustang Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Mustang Bio to buy it.

The correlation of Mustang Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Mustang Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Mustang Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Mustang Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Mustang Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mustang Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mustang Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mustang Bio Stock:

How To Invest In Mustang

Details

Is Mustang Stock a good investment?

Details

What is Mustang Bio's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Mustang Bio Correlation against competitors.

To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.

You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Will Biotechnology sector continue expanding? Could Mustang diversify its offerings? Factors like these will boost the valuation of Mustang Bio. Expected growth trajectory for Mustang significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Mustang Bio data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.

Earnings Share

(6.71)

Revenue Per Share

(0)

Return On Assets

(0.08)

Return On Equity

(4.19)

Mustang Bio's market price often diverges from its book value, the accounting figure shown on Mustang's balance sheet. Smart investors calculate Mustang Bio's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Mustang Bio's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.

Understanding that Mustang Bio's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Mustang Bio represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Mustang Financial Statements From 2010 to 2026

Mustang Bio Balance Sheet

Mustang Bio Income Statement

Mustang Bio Cash Flow Statement

Financial Ratios

Mustang Bio Valuation Data

Mustang Fundamental Market Drivers

Mustang Upcoming Events

About Mustang Bio Financial Statements

Pair Trading with Mustang Bio

Moving together with Mustang Stock

Moving against Mustang Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY